STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
IN THE MATTER OF RULE-MAKING PROCEEDINGS BEFORE THE
CONTROLLED SUBSTANCES BOARD
AFFIRMATIVE ACTION ORDER OF THE
CONTROLLED SUBSTANCES BOARD
FINDINGS
1. On December 13, 2017, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register placing MT-45 into schedule I of the federal Controlled Substances Act. The scheduling action is effective January 12, 2018.
2. The Controlled Substances Board did not receive an objection to similarly treating MT-45 as a schedule I under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order designating MT-45 as a controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rulemaking, designating MT-45 as a schedule I controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats MT-45 under chapter 961, Stats. by creating the following: CSB 2.61 Addition of MT-45 to schedule I. Section 961.14 (2) (rk) Stats., is created to read: 961.14 (2) (rk) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)
This order shall take effect on January 22, 2018 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated January 16, 2018 
Doug Englebert, Chair
Controlled Substances Board
